Mead Johnson to pay $13.5 million in damages for false advertising

A Virginia jury awarded $13.5 million in damages to manufacturers of store-brand infant formula. PBM Products had contested Mead Johnson’s claims that “only Enfamil LIPIL is clincally proven to improve brain and eye development.”

Mead Johnson uses aggressive marketing tactics, such as hospital marketing, to convince families to purchase its high-priced formula. Mead Johnson’s product costs twice as much as the PBM products sold at Sam’s Club, Target, Kroger and Walgreen’s, the company told the associated press.

Mead Johnson recently drew fire from breastfeeding advocates for marketing Lipil as “The Breast Milk Formula”, despite evidence that the long chain polyunsaturated fatty acids added to infant formula have no beneficial effect for healthy infants.

Leave a Reply

Your email address will not be published.